Cyclacel Pharmaceuticals, Inc.

NasdaqCM:CYCC Stock Report

Market Cap: US$25.9m

Cyclacel Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CYCC?
Owner TypeNumber of SharesOwnership Percentage
Institutions23,6900.11%
Private Companies1,718,7507.98%
Individual Insiders19,806,25091.9%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 14069.6%.

Top Shareholders

Top 25 shareholders own 126.5% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
93.9%
Sing Wong
12,164,301US$24.3m0%no data
18.8%
David Lazar
2,438,824US$4.9m0%no data
13.3%
Suria Sukses Engineering Sdn Bhd
1,718,750US$3.4m0%no data
0.12%
Kok Tan
15,625US$31.3k0%no data
0.12%
Jien Ho
15,625US$31.3k0%no data
0.12%
Kee Ho
15,625US$31.3k0%no data
0.053%
Shay Capital LLC
6,932US$13.9k0%no data
0.03%
Geode Capital Management, LLC
3,904US$7.8k478%no data
0.03%
UBS Asset Management AG
3,890US$7.8k31.6%no data
0.025%
Citadel Advisors LLC
3,245US$6.5k0%no data
0.0078%
Two Sigma Securities, LLC, Asset Management Arm
1,013US$2.0k-43.3%no data
0.0074%
Point72 Asset Management, L.P.
958US$1.9k0%no data
0.0074%
Two Sigma Investments, LP
955US$1.9k0%no data
0.0069%
Acadian Asset Management LLC
892US$1.8k0%no data
0.0069%
XTX Holdings Limited, Asset Management Arm
892US$1.8k0%no data
0.003%
Tower Research Capital Europe Limited
390US$780.111.8%no data
0.0028%
The Vanguard Group, Inc.
362US$723.10%no data
0.00092%
Schonfeld Strategic Advisors LLC
119US$238.40%no data
0.00058%
SBI Holdings Inc., Asset Management Arm
75US$150.350%no data
0.00009%
Archer Investment Corporation
12US$23.30%no data
0.00009%
Financial Gravity Companies, Inc.
12US$23.30%no data
0.00009%
Financial Gravity Asset Management, Inc.
12US$23.30%no data
0.00006%
Activest Wealth Management, LLC
8US$15.60%no data
0.00005%
Osaic Wealth, Inc. , Asset Management Arm
7US$13.00%no data
0.00004%
Morgan Stanley, Investment Banking and Brokerage Investments
5US$10.40%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/19 03:22
End of Day Share Price 2025/05/19 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cyclacel Pharmaceuticals, Inc. is covered by 11 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael KingCitizens JMP Securities, LLC
Andrew FeinH.C. Wainwright & Co.
Kimberly LeeJanney Montgomery Scott LLC